Carlin Consumer Health Acquires Infirst USA Holdings.

MANews-(C)2009-2023

New York-based consumer health business Carlin Consumer Health has acquired Connecticut-based marketing provider Infirst USA Holdings, LLC, the parent company of Infirst Healthcare Inc., the company said.

Terms of the transaction were not disclosed.

Infirst is the marketer of two iconic digestive health brands, Mylanta and Mylicon, pursuant to a trademark licensing agreement with McNeil Consumer Pharmaceuticals Co. As part of the transaction, Infirst will now become a wholly owned subsidiary of Carlin Consumer Health.

Carlin Consumer Health is sponsored by Hildred Capital Management, Bourne Partners Strategic Capital, and The Emerson Group--and currently markets the OTC acid reducer brand, Zegerid OTC.

Sidley Austin LLP served as legal advisor to Carlin and Wilson Sonsini Goodrich Rosati acted as legal advisor to Infirst. Stifel acted as exclusive...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT